Monitoring of the coronavirus SARS-CoV-2 in wastewater – what the monitoring has shown us so far and where it is headed
Since April 2020, the presence of the coronavirus SARS-CoV-2 in wastewater has been monitored at TGM WRI, p.r.i. The method of detection is similar to that of clinical samples, ie the presence of a specific fragment of viral RNA is detected by PCR.
The paper provides actual clear information about viruses and coronaviruses, including SARS-CoV-2, the possibility of contamination of surface water and wastewater by this virus.
Determination of selected illicit drugs in wastewater using liquid chromatography tandem mass spectrometry
The wastewater-based epidemiology approach to the analysis of illicit drugs was conceptualized in 2001 and for the first time was applied in 2005 for cocaine estimation in Italy. Further, other illicit drugs as heroine, cannabis and amphetamine have been estimated.
The article informs about regular, almost two-year long monitoring of municipal wastewater at selected sampling points of the Prague sewerage network. Selected illicit drugs (e.g. methamphetamine, MDMA, THC, cocaine), nicotine and its metabolites and the ethanol metabolite ethyl sulphate are monitored in municipal wastewater.
The paper outlines the possibilities of using the epidemiological approach to the analysis of municipal wastewater to monitor the lifestyle of the population, its dietary habits, the environmental impacts on humans, the assessment of the state of health of the population and monitoring the consumption of illicit drugs and other substances in the monitored population
Use of wastewater‑based epidemiology for monitoring of illicit drugs consumption in Czech and international context
This paper presents a brief summary of information about the project Determination of the amount of illicit drugs and their metabolites in municipal wastewater – new tool for obtaining of complementary data on illicit drug consumption in the Czech Republic and about the 2nd International Conference on “Wastewater‑based drug epidemiology“, which was held from 11.–15. 10. 2015 in Ascona, Switzerland.